MU
36
-6
AEP
58
4
ED
55
3
INTU
56
3
GS
78
3
FDX
44
-2
HIG
75
4
ALLE
39
-2
BWA
48
-5
BRK.B
45
2
AMT
45
2
BEN
48
-4
WY
60
-2
RSG
76
2
PM
66
4
SO
62
3
EFX
41
-5
SPG
63
7
HBI
59
4
PPG
61
-4
MU
36
-6
AEP
58
4
ED
55
3
INTU
56
3
GS
78
3
FDX
44
-2
HIG
75
4
ALLE
39
-2
BWA
48
-5
BRK.B
45
2
AMT
45
2
BEN
48
-4
WY
60
-2
RSG
76
2
PM
66
4
SO
62
3
EFX
41
-5
SPG
63
7
HBI
59
4
PPG
61
-4
Financhill
Back

ProShares Ultra FTSE Europe Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
73

UPV
ProShares Ultra FTSE Europe

Last Price:
56.54
Seasonality Move:
10.12%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
138.01
Seasonality Move:
14.88%
Buy
73
ProShares Ultra FTSE Europe (UPV) is a Buy

Is ProShares Ultra FTSE Europe a Buy, Sell or Hold?

  • The current ProShares Ultra FTSE Europe [UPV] share price is $56.65. The Score for UPV is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
  • UPV is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

UPV Stock Price Chart

What is ProShares Ultra FTSE Europe's stock price today?

  • The ProShares Ultra FTSE Europe share price today is $56.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UPV is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

UPV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.91 Sell
Relative Strength Index (14 RSI): 28.26 Sell
Chaikin Money Flow: 283 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (57.03 - 62.31) Sell
Bollinger Bands (100): (60.44 - 67.58) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

UPV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.83 Sell
20-day SMA: 58.74 Sell
50-day SMA: 63.13 Sell
200-day SMA: 63.27 Sell
8-day EMA: 57.06 Sell
20-day EMA: 58.72 Sell
50-day EMA: 61.51 Sell
200-day EMA: 61.99 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

ProShares Ultra FTSE Europe Earnings Growth & UPV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

ProShares Ultra FTSE Europe Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):